Highlights and Quick Summary
- Capital Stock Change for the quarter ending September 30, 2023 was $318 Thousand (a 324.0% increase compared to previous quarter)
- Year-over-year quarterly Capital Stock Change decreased by -99.83%
- Annual Capital Stock Change for 2022 was $186 Million (a -31.38% decrease from previous year)
- Annual Capital Stock Change for 2021 was $270 Million (a 673.49% increase from previous year)
- Annual Capital Stock Change for 2020 was $35 Million (a 250.21% increase from previous year)
- Twelve month Capital Stock Change ending September 30, 2023 was $186 Million (a 0.14% increase compared to previous quarter)
Trailing Capital Stock Change for the last four month:
| 30 Sep '23 | 30 Jun '23 | — | — |
|---|---|---|---|
| $186 Million | $186 Million | — | — |
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Capital Stock Change of Prime Medicine, Inc.
Most recent Capital Stock Changeof PRME including historical data for past 10 years.Interactive Chart of Capital Stock Change of Prime Medicine, Inc.
Prime Medicine, Inc. Capital Stock Change for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $0.32 | $0.08 | $0.07 | – | – |
| 2022 | – | – | $185.47 | $0.06 | $185.54 |
| 2021 | – | – | – | $270.36 | $270.36 |
| 2020 | – | – | – | – | $34.95 |
| 2019 | – | – | – | – | $9.98 |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology